CAS: 848133-17-5
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | HKI 357 REF: IN-DA00GAICCAS: 848133-17-5 | 98% | To inquire | Tue 12 Aug 25 |
 | HKI-357 REF: 54-BUP04975CAS: 848133-17-5 | ≥95% | 92.00 €~1,102.00 € | Wed 13 Aug 25 |
 | HKI-357 REF: TM-T11569CAS: 848133-17-5 | 99.91% | 65.00 €~1,111.00 € | Tue 14 Oct 25 |
 | HKI 357 REF: 3D-YIB13317CAS: 848133-17-5 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00GAIC
| 10mg | 149.00 € | ||
| 25mg | 213.00 € | ||
| 50mg | 335.00 € | ||
| 100mg | 592.00 € |
Estimated delivery in United States, on Tuesday 12 Aug 2025
Ref: 54-BUP04975
| 1mg | 92.00 € | ||
| 5mg | 185.00 € | ||
| 10mg | 289.00 € | ||
| 25mg | 533.00 € | ||
| 50mg | 771.00 € | ||
| 100mg | 1,102.00 € |
Estimated delivery in United States, on Wednesday 13 Aug 2025
HKI-357
CAS:848133-17-5
HKI-357 irreversibly inhibits EGFR/ERBB2 (IC50: 34/33 nM), blocks EGFR Y1068 autophosphorylation, and AKT/MAPK phosphorylation.
Formula:
C31H29ClFN5O3
Purity:
99.91%
Color and Shape:
Solid
Molecular weight:
574.05
Ref: TM-T11569
| 1mg | 65.00 € | ||
| 5mg | 131.00 € | ||
| 10mg | 205.00 € | ||
| 25mg | 391.00 € | ||
| 50mg | 568.00 € | ||
| 100mg | 825.00 € | ||
| 200mg | 1,111.00 € | ||
| 1mL*10mM (DMSO) | 165.00 € |
Estimated delivery in United States, on Tuesday 14 Oct 2025
HKI 357
CAS:848133-17-5
Please enquire for more information about HKI 357 including the price, delivery time and more …
Formula:
C31H29ClFN5O3
Purity:
Min. 95%
Molecular weight:
574.05 g/mol
Ref: 3D-YIB13317
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
